Get started
Roche Holding Ltd Sponsored ADRRoche Holding Ltd Sponsored ADRRoche Holding Ltd Sponsored ADR

Roche Holding Ltd Sponsored ADR

No trades
OverviewFinancialsNewsCommunityForecastsSeasonalsBondsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪313.48 B‬ EUR
Dividend yield (indicated)
1.49%
Price to earnings Ratio (TTM)
23.830
Basic EPS (TTM)
2.065 EUR
Net income (FY)
‪13.20 B‬ EUR
Revenue (FY)
‪63.07 B‬ EUR
Shares float
‪5.51 B‬
Beta (1Y)
0.40

About Roche Holding Ltd


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Thomas Schinecker
Website
roche.com
Headquarters
Basel
Founded
1896
IPO date
May 4, 2001
Identifiers
3
ISIN US7711951043
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Check out other big names from the same industry as RHO6.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


CHGCY5317644
Roche Holdings, Inc. 2.607% 13-DEC-2051
Yield to maturity
5.42%
Maturity date
Dec 13, 2051
R
CHGCY5766486
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
5.34%
Maturity date
Mar 8, 2054
R
CHGCY5766485
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
5.33%
Maturity date
Mar 8, 2054
G
CHGCY3666852
Genentech, Inc. 5.25% 15-JUL-2035
Yield to maturity
5.30%
Maturity date
Jul 15, 2035
R
CHGCY4184535
Roche Holdings, Inc. 4.0% 28-NOV-2044
Yield to maturity
5.19%
Maturity date
Nov 28, 2044
R
CHGCY5766483
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
5.15%
Maturity date
Mar 8, 2034
R
CHGCY5766481
Roche Holdings, Inc. 4.909% 08-MAR-2031
Yield to maturity
5.07%
Maturity date
Mar 8, 2031
R
CHGCY4391962
Roche Holdings, Inc. 7.0% 01-MAR-2039
Yield to maturity
5.01%
Maturity date
Mar 1, 2039
R
CHGCY5766479
Roche Holdings, Inc. 4.79% 08-MAR-2029
Yield to maturity
4.95%
Maturity date
Mar 8, 2029
R
CHGCY6244754
Roche Holdings, Inc. 4.666% 02-DEC-2035
Yield to maturity
4.76%
Maturity date
Dec 2, 2035
R
CHGCY5766484
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
4.64%
Maturity date
Mar 8, 2034

See all RHO6 bonds 

ETFs holding the stock


APIE
ActivePassive International Equity ETF
Weight
1.40%
Market value
‪13.90 M‬
USD
LIFE.B
Evolve Global Healthcare Enhanced Yield Fund
Weight
5.42%
Market value
‪13.28 M‬
USD
LIFE
Evolve Global Healthcare Enhanced Yield Fund
Weight
5.42%
Market value
‪13.28 M‬
USD
LIFE.U
Evolve Global Healthcare Enhanced Yield Fund Trust Units USD Unhedged
Weight
5.42%
Market value
‪13.28 M‬
USD
INCM
Franklin Income Focus ETF Income Focus ETF
Weight
1.02%
Market value
‪12.69 M‬
USD
AQEC
AQE Core ETF
Weight
1.87%
Market value
‪11.28 M‬
USD
QLTI
GMO International Quality ETF
Weight
4.04%
Market value
‪11.16 M‬
USD
CANC
Tema Oncology ETF
Weight
4.29%
Market value
‪6.46 M‬
USD
HRTS
Tema Heart & Health ETF
Weight
5.34%
Market value
‪3.02 M‬
USD
YLDE
Franklin ClearBridge Enhanced Income ETF
Weight
1.87%
Market value
‪2.15 M‬
USD
SPWO
SP Funds S&P World (ex-US) ETF
Weight
1.79%
Market value
‪1.98 M‬
USD

Explore more ETFs